WST

WST Total Liabilities

$1.09BQuarterly · USD

Period ending:

WST FY Total LiabilitiesUSD
WST FY Total Liabilities1985-12-31: $59.50M1986-12-31: $98.50M1987-12-31: $124.30M1988-12-31: $127.50M1989-12-31: $124.20M1990-12-31: $155.70M1991-12-31: $152.10M1992-12-31: $125.70M1993-12-31: $108.40M1994-12-31: $168.20M1995-12-31: $225.80M1996-12-31: $225.10M1997-12-31: $199.80M1998-12-31: $277.40M1999-12-31: $319.80M2000-12-31: $343.30M2001-12-31: $334.50M2002-12-31: $328.10M2003-12-31: $366.00M2004-12-31: $348.10M2005-12-31: $489.50M2006-12-31: $498.90M2007-12-31: $694.70M2008-12-31: $681.60M2009-12-31: $691.90M2010-12-31: $668.60M2011-12-31: $744.20M2012-12-31: $835.10M2013-12-31: $765.20M2014-12-31: $712.80M2015-12-31: $671.20M2016-12-31: $599.20M2017-12-31: $582.90M2018-12-31: $582.60M2019-12-31: $768.20M2020-12-31: $939.30M2021-12-31: $978.40M2022-12-31: $931.90M2023-12-31: $948.50M2024-12-31: $961.10M2025-12-31: $1.09B$1.09B$0.00
1985-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

WST total liabilities history

Total amount the company owes to creditors. The available annual fiscal periods series contains 41 observations from Dec 31, 1985 to Dec 31, 2025.

West Pharmaceutical Services Total Liabilities — Annual fiscal periods (USD)
Period endingTotal Liabilities (USD)
1,094,000,000
961,100,000
948,500,000
931,900,000
978,400,000
939,300,000
768,200,000
582,600,000
582,900,000
599,200,000
671,200,000
712,800,000
765,200,000
835,100,000
744,200,000
668,600,000
691,900,000
681,600,000
694,700,000
498,900,000
489,500,000
348,100,000
366,000,000
328,100,000
334,500,000
343,300,000
319,800,000
277,400,000
199,800,000
225,100,000
225,800,000
168,200,000
108,400,000
125,700,000
152,100,000
155,700,000
124,200,000
127,500,000
124,300,000
98,500,000
59,500,000

Compare total liabilities

All WST financial metrics · WST stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.